Prostate Cancer Diagnosis & Treatment | AMO Oncology Centre

address Room 1311-1312, 13/F, Ocean Center, Harbour City, 5 Canton Road, Tsim Sha Tsui
Prostate cancer Treatment
Prostate cancer

As one of the most common cancers among men, prostate cancer is the most prevalent cancer of male reproductive system. Patients with prostate cancer are mostly elders and some are unaware that they have prostate cancer till their death. Europe and the United States have a higher incidence rate than Asia. Autopsy results show that 30% of males aged over 50 have prostate cancer cells and the percentage is up to 80% in males aged over 70. However, most prostate cancers are benign and are easier to treat in comparison with other cancers.

Surgical excision
Prostate cancer tissues can be completely removed by surgery, namely laparotomy, minimally invasive surgery or minimally invasive surgery using robotic arms. However, it may cause such side effects as urinary incontinence and erectile dysfunction.
Killing tumors by high-energy radiant rays, the therapy can be applied internally or externally. At present, external radiotherapy is applied most of the time. However, it has such side effects as fatigue, frequent urination, diarrhea, burning skin pain at the area of treatment, and may also impair the functions of rectum and bladder.
Usually involves only a single low-dose injection, which is often applied simultaneously with hormone therapy to control tumors more efficiently.
Hormone therapy
At present, an injected drug that interferes with the secretion of pituitary gland can indirectly suppress the production of testosterone to deliver the same effect as surgery, so it can free patients from the negative psychological impact arising from a surgery. This therapy aims to inhibit the secretion of male hormones (testosterone) and disrupt androgen receptors. However, hormone therapy does not fully cure prostate cancer and the efficacy is not long lasting.
Radium-223 therapy
Radium-223 will release alpha particles to kill tumors, which is often applied on patients with advanced prostate cancer. This therapy has been proven safe in overseas clinical trials, in which incidence of myelosuppression remains consistently low and with no correlation with secondary metastasis.
  • AM730, 前列腺癌的放射治療,, 2016年8月5日
  • 大紀元, 晚期前列腺癌 有藥可治,, 2015年8月15日
  • 灼見名家, 陳亮祖醫生:前列腺癌的治療方法,陳亮祖醫生:前列腺癌的治療方法/
  • 香港防癌會, 前列腺癌,